Navigation Links
FDA Approves Erwinaze to Treat a Form of Leukemia
Date:11/18/2011

SILVER SPRING, Md., Nov. 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.

Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze.

"The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.

The safety and effectiveness of Erwinaze was evaluated in one clinical trial of 58 patients. Additional safety data was collected from the Erwinaze Master Treatment Protocol (EMTP), an expanded access program that enrolled 843 patients. Patients in both studies were unable to continue receiving pegaspargase or asparaginase derived from E. coli due to allergic reactions.

In the trial to suppo
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
2. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
3. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
4. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
5. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
6. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
7. FDA Approves Onfi To Treat Severe Type of Seizures
8. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
9. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
10. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
11. FDA Approves Combination Therapy Juvisync
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , Boston Scientific to acquire leading male urology ... $1.65 billion, with $1.6 billion in upfront cash ... Health business , Divestiture furthers Endo,s strategic ... Endo International plc (NASDAQ: ENDP ) (TSX: ... with Boston Scientific (NYSE: BSX ), under which ...
(Date:3/2/2015)... , March 2, 2015  BioMed Realty Trust, Inc. ... recaptured approximately 313,000 square feet of space in the ... in the world through the termination of Vertex Pharmaceuticals, ... effective February 28, 2015. BioMed Realty will ... will immediately begin to reposition the properties to meet ...
(Date:3/1/2015)... -- An innovative interventional radiology treatment has been found ... their headaches, according to research being presented at ... Annual Scientific Meeting . Clinicians at Albany Medical ... State College in Saratoga Springs used a treatment ... give patients enough ongoing relief that they required ...
Breaking Medicine Technology:Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 2Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 3BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 2BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 3Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4
... ConvaTec Healthcare, a world-leading developer, manufacturer and marketer ... today announced that in connection with a refinancing of ... facilities and in combination with new senior secured credit ... Notes and Senior Notes. The offering of the new ...
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... in-vitro diagnostic ("IVD") company, today announced that its ... ("GP Medical") and Beijing Yuande Bio-Medical Engineering Co., ... 415th, respectively, in the Deloitte Technology Fast 500 ...
Cached Medicine Technology:ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering 2ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering 3China Medical Technologies Announces its Subsidiaries, GP Medical and Beijing Yuande, Ranked 12th and 415th, respectively, in Deloitte Technology Fast 500 Asia Pacific 2010 Program 2
(Date:3/1/2015)... (PRWEB) March 01, 2015 Women’s Excellence ... Obstetric terms on their website. There are over ... all the time. , “This gives our patients a ... use medical terminology that they may not understand. With this ... (which is mobile optimized) and find terms and phrases that they ...
(Date:3/1/2015)... NC (PRWEB) March 01, 2015 Researchers ... reason that so many sheet metal workers contract malignant ... this new report on its website. Click here ... Center for Construction Research and Training monitored 17,345 sheet ... a disproportionate number of them died of mesothelioma ...
(Date:3/1/2015)... Indiana (PRWEB) March 01, 2015 ... statewide Network Service Provider, announces NewWays Networking, LLC ... “By working with IFN, NewWays is well ... meet client’s demand for Internet bandwidth in rural ... , According to Cory Childs IFN Enterprise ...
(Date:3/1/2015)... February 28, 2015 CrossFit Attollo is a ... are offering a special discount to new members. Now ... for a three month contract will receive their fourth month ... would cost members $440. The three month contract is ... and then the fourth month comes in at only $55. ...
(Date:2/28/2015)... February 28, 2015 In a recent ... of Game Change Athlete Development Services ... about the benefits of athlete development and player engagement ... the unique challenges that athletes face and how off-field ... success. , Fletcher became involved in athlete development issues ...
Breaking Medicine News(10 mins):Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3
... Scientists have identified the receptor in cells of the peripheral ... to sense cold. ,The finding, reported on-line ... the key mechanisms by which the body detects temperature sensation. ... mediates how the body experiences intense stimuli temperature, in ...
... (FDA) today approved Torisel (temsirolimus) for the treatment of a ... carcinoma. Torisel was approved based on a study that ... renal cell carcinoma. The drug is an enzyme inhibitor, a ... ,'We have made significant advances in the battle ...
... is only a pretext for multinational corporations to take control ... in US charge. With sales of over $35 billion ... it takes to buy up pristine springs in some of ... Nestl, which controls one-third of the U.S. market and sells ...
... combined with sulphur to improve its overall strength and durability. ... to reform and reuse old tyres. The only way ... a process that releases heavy metals and other pollutants and ... and colleagues at Swansea University, UK, have shown that spinning ...
... will have a new -- virtually pain free -- ... Health System (SJMHS) announced today it will begin treating ... Wednesday, June 6th. ,This advanced radiosurgery system ... previously inoperable tumors, with astounding accuracy and with little ...
... to emergency needs and low donor turnout. The American Red ... can, to donate blood. ,As of this ... Red Cross had no units of Type O-negative -- the ... below a one-day supply. ,Shortages of Type O-negative ...
Cached Medicine News:Health News:Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh 2Health News:Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh 3Health News:FDA: New Drug for Advance Kidney Cancer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5Health News:Advanced Cancer Treatment Brings New Hope to Michigan Patient 2
DMSO-resistant microplate sealing film...
Amplification Tape 96 featuring 3M adhesive technology. Good optical quality. Minimal autofluorescence. Certified RNase and DNase free....
Empore Sealing Tape Pads are ideal for covering a 96 well plate during storage or transfer to another work station. Not intended for use with auto-injectors....
... Microseal 'B' seals provide an adhesive-based ... microplates. The aggressive adhesive layer ensures secure ... cycling, and tight sealing during thermal cycling ... heated lid. The perforated end-tabs can be ...
Medicine Products: